SPOR and xEVMPD Stakeholder Engagement Webinars : SPOR Data Governance, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 4 October 2024, 10:00 (CEST) to 4 October 2024, 12:00 (CEST)

SPOR and xEVMPD Stakeholder Engagement Webinars : Organisation Management Service (OMS), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 9 October 2024, 10:00 (CEST) to 9 October 2024, 12:00 (CEST)

Template - Request for advice on the orphan device status pursuant to Article 61(2) of Regulation (EU) 2017/745 and MDCG 2024-10

Template - Request for advice on the clinical development strategy or clinical data required for the clinical evaluation pursuant to Article 61(2) or Article 106(11) of Regulation (EU) 2017/745 and MDCG 2024-10 on from the Expert Panels

EMEA-003516-PIP01-23

Start of procedure: Extension of marketing authorisation (28 February 2025 - 27 March 2025)

Start of procedure: Type II variation - extension of indication under evaluation by the CHMP (28 February 2025 - 27 March 2025)

Scientific advice and protocol assistance adopted during the CHMP meeting 24-27 March 2025

Procedural guidance to scientific committeesꞌ members and experts on completing the European Medicines Agencyꞌs declaration of interests in the Experts Management Tool

ICMRA Summit 2025, European Medicines Agency, Amsterdam, the Netherlands, from 21 October 2025 to 24 October 2025